BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 22902638)

  • 21. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
    Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
    J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of protein expression levels and DNA methylation status of breast cancer metastasis genes by anthracycline-based chemotherapy and the demethylating agent decitabine.
    Ari F; Napieralski R; Ulukaya E; Dere E; Colling C; Honert K; Krüger A; Kiechle M; Schmitt M
    Cell Biochem Funct; 2011 Dec; 29(8):651-9. PubMed ID: 21887697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of candidate methylation-responsive genes in ovarian cancer.
    Menendez L; Walker D; Matyunina LV; Dickerson EB; Bowen NJ; Polavarapu N; Benigno BB; McDonald JF
    Mol Cancer; 2007 Jan; 6():10. PubMed ID: 17254359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of novel target genes by an epigenetic reactivation screen of renal cancer.
    Ibanez de Caceres I; Dulaimi E; Hoffman AM; Al-Saleem T; Uzzo RG; Cairns P
    Cancer Res; 2006 May; 66(10):5021-8. PubMed ID: 16707423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
    Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter methylation assay of SASH1 gene in breast cancer.
    Sheyu L; Hui L; Junyu Z; Jiawei X; Honglian W; Qing S; Hengwei Z; Xuhui G; Qinghe X; Lin H
    J BUON; 2013; 18(4):891-8. PubMed ID: 24344014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells.
    John Mary DJS; Sikarwar G; Kumar A; Limaye AM
    Mol Cell Endocrinol; 2020 Mar; 504():110701. PubMed ID: 31926189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic oxidative stress causes estrogen-independent aggressive phenotype, and epigenetic inactivation of estrogen receptor alpha in MCF-7 breast cancer cells.
    Mahalingaiah PK; Ponnusamy L; Singh KP
    Breast Cancer Res Treat; 2015 Aug; 153(1):41-56. PubMed ID: 26208486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
    Chang YW; Singh KP
    PLoS One; 2017; 12(3):e0174227. PubMed ID: 28323900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for epigenetically masked genes in colorectal cancer Using 5-Aza-2'-deoxycytidine, microarray and gene expression profile.
    Khamas A; Ishikawa T; Shimokawa K; Mogushi K; Iida S; Ishiguro M; Mizushima H; Tanaka H; Uetake H; Sugihara K
    Cancer Genomics Proteomics; 2012; 9(2):67-75. PubMed ID: 22399497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
    Gallagher WM; Bergin OE; Rafferty M; Kelly ZD; Nolan IM; Fox EJ; Culhane AC; McArdle L; Fraga MF; Hughes L; Currid CA; O'Mahony F; Byrne A; Murphy AA; Moss C; McDonnell S; Stallings RL; Plumb JA; Esteller M; Brown R; Dervan PA; Easty DJ
    Carcinogenesis; 2005 Nov; 26(11):1856-67. PubMed ID: 15958521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15.
    Ishiguro M; Iida S; Uetake H; Morita S; Makino H; Kato K; Takagi Y; Enomoto M; Sugihara K
    Ann Surg Oncol; 2007 May; 14(5):1752-62. PubMed ID: 17195906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into significant pathways and gene interaction networks underlying breast cancer cell line MCF-7 treated with 17β-estradiol (E2).
    Huan J; Wang L; Xing L; Qin X; Feng L; Pan X; Zhu L
    Gene; 2014 Jan; 533(1):346-55. PubMed ID: 23978611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
    Wargon V; Fernandez SV; Goin M; Giulianelli S; Russo J; Lanari C
    Breast Cancer Res Treat; 2011 Apr; 126(2):319-32. PubMed ID: 20440553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide profiling in melatonin-exposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin.
    Lee SE; Kim SJ; Yoon HJ; Yu SY; Yang H; Jeong SI; Hwang SY; Park CS; Park YS
    J Pineal Res; 2013 Jan; 54(1):80-8. PubMed ID: 22856590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tamoxifen epigenetically modulates CXCL12 expression in MCF-7 breast cancer cells.
    Pietkiewicz PP; Lutkowska A; Lianeri M; Jagodzinski PP
    Biomed Pharmacother; 2010 Jan; 64(1):54-7. PubMed ID: 19748759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen-regulated gene networks in human breast cancer cells: involvement of E2F1 in the regulation of cell proliferation.
    Stender JD; Frasor J; Komm B; Chang KC; Kraus WL; Katzenellenbogen BS
    Mol Endocrinol; 2007 Sep; 21(9):2112-23. PubMed ID: 17550982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early membrane initiated transcriptional effects of estrogens in breast cancer cells: First pharmacological evidence for a novel membrane estrogen receptor element (ERx).
    Kampa M; Notas G; Pelekanou V; Troullinaki M; Andrianaki M; Azariadis K; Kampouri E; Lavrentaki K; Castanas E
    Steroids; 2012 Aug; 77(10):959-67. PubMed ID: 22406407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of novel epigenetically inactivated gene PAMR1 in breast carcinoma.
    Lo PH; Tanikawa C; Katagiri T; Nakamura Y; Matsuda K
    Oncol Rep; 2015 Jan; 33(1):267-73. PubMed ID: 25370079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.